Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.11 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |